Showing results (51-60 of 89) with videos related to

Sort By:
Pageof 9
Anticancer Research|May 4, 2005
Identification of serum proteins related to adverse effects induced by docetaxel infusion from protein expression profiles of serum using SELDI ProteinChip systemYuji Heike, Mami Hosokawa, Shozo Osumi, et al.
British Journal of Haematology|March 29, 2002
Effect of fluconazole prophylaxis on fungal blood cultures: an autopsy-based study involving 720 patients with haematological malignancyMasahiro Kami, Utako Machida, Katsuko Okuzumi, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 23, 2008
Impact of T cell chimerism on clinical outcome in 117 patients who underwent allogeneic stem cell transplantation with a busulfan-containing reduced-intensity conditioning regimenBungo Saito, Takahiro Fukuda, Hiroki Yokoyama, et al.
International Journal of Hematology|August 4, 2010
Hematopoietic stem cell transplantation for therapy-related myelodysplastic syndrome and acute leukemia: a single-center analysis of 47 patientsHiroki Yokoyama, Shin-ichiro Mori, Yukio Kobayashi, et al.
Transplantation|March 13, 2002
Response-oriented preemptive therapy against cytomegalovirus disease with low-dose ganciclovir: a prospective evaluationYoshinobu Kanda, Shin Mineishi, Takeshi Saito, et al.
American Journal of Hematology|July 26, 2006
Nutritional support for patients suffering from intestinal graft-versus-host disease after allogeneic hematopoietic stem cell transplantationOsamu Imataki, Shigetoshi Nakatani, Terumi Hasegawa, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 21, 2004
Incidence of invasive aspergillosis after allogeneic hematopoietic stem cell transplantation with a reduced-intensity regimen compared with transplantation with a conventional regimenRie Kojima, Masahiro Kami, Yasuhito Nannya, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 21, 2007
Comparable antileukemia/lymphoma effects in nonremission patients undergoing allogeneic hematopoietic cell transplantation with a conventional cytoreductive or reduced-intensity regimenDai Maruyama, Takahiro Fukuda, Ruri Kato, et al.
Transplantation|November 7, 2007
Hyperglycemia during the neutropenic period is associated with a poor outcome in patients undergoing myeloablative allogeneic hematopoietic stem cell transplantationShigeo Fuji, Sung-Won Kim, Shin-ichiro Mori, et al.
American Journal of Hematology|March 2, 2013
In vivo T-cell depletion with alemtuzumab in allogeneic hematopoietic stem cell transplantation: Combined results of two studies on aplastic anemia and HLA-mismatched haploidentical transplantationYoshinobu Kanda, Kumi Oshima, Shinichi Kako, et al.
Pageof 9